Vaccines absorbable by the transmucosal way

Details Vaccines absorbable by the transmucosal way Vaccines absorbable by the transmucosal way

2007-03-06

2007-03-06

Navarro, Mark (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S193100, C424S197110, C424S234100

Reexamination Certificate

active

11189221

ABSTRACT:
The main object of the present invention is to provide polysaccharide-coated antigens derivatised with lectins for pharmaceutical use. In the vaccines, polysaccharides are preferably selected from the group consisting of chitosan, low-molecular-weight and high-deacetylation-degree chitosan, methyl glycol. chitosan, alginic acid, polymannuronic acid and salts or derivatives thereof. In the vaccines of the invention, antigens are microorganisms, infectious agents or constituents thereof, hormones, enzymes, proenzymes, narcotics, bioactive peptides, metabolites, biological precursors, cell constituents, allergens, and the lectins are of vegetable origin.

REFERENCES:
Sorensen et al (Acta Pathologica Microbiologica et Immunologica Scandinavica- Section C Immunology, vol. 92, No. 6, 1984, pp. 351-356).

Affiliated with

Also associated with

Rating

Vaccines absorbable by the transmucosal way does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines absorbable by the transmucosal way, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines absorbable by the transmucosal way will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3737070